CIS Achieves Significant Business, Growth Milestones in 2012

CIS strengthens its position as a leading life-sciences consulting firm by attaining significant business, growth milestones in 2012.

Compliance Implementation Services (CIS) continues to strengthen its position as a leading life sciences consulting firm in its eighth year of business as demonstrated by several significant

Expanded client base to 150 companies representing more than half of the largest 50
pharmaceutical, biotech and medical device companies.

Added 6 director-level hires, while also expanding staff within operations support teams.

Opened an office in Bristol, TN, relocated to a larger office space in Philadelphia, expanded to a second floor in our Raleigh office, and added new management and staff in the San Francisco office.

Recognized in Inc. Magazine's 500/500, The Philly 100, and the Triangle Business Journal's "Fast 50" for client growth and job creation.

Participated in more than 40 industry events where CIS experts presented in 37 podium and panel discussions.

"We're proud that we've been able to maintain strong growth during an economic year that was tough on our clients and our industry," said Toni Barsh, Executive Vice President and Co-founder. "CIS' focus has been on addressing the needs of our clients and growing our services to support them. We're pleased with our progress and deeply honored by the industry's acknowledgment of our achievements."

2012 brought its share of challenges to the life sciences industry: pharmaceutical companies lost revenue to drug patent expirations that resulted in the looming patent cliff; the U.S. Government handed down unprecedented fines in settlements related to allegations of non-compliance; and layoffs mounted as companies tried to bring expenses in line with business growth.

The year also brought transition to the forefront as companies followed the Supreme Court ruling on the Affordable Care Act and the re-election of President Obama. The implications of these sweeping reforms were felt throughout 2012 as manufacturers prepared for and managed the uncertainty and lack of guidance
surrounding the AMP Final Rule and implementation of the Sunshine Act.

"Throughout it all, CIS has helped our clients address these challenges and prepare for what follows in 2013 by
engaging in dialogue with our peers and by closely following industry and agency announcements," said Barsh. "Our experts have provided the leadership, knowledge, and guidance to help clients make sense of it all, stay proactive, and remain compliant."

About Compliance Implementation Services (CIS)

Compliance Implementation Services (CIS) is a leading life sciences consulting firm specializing in compliance and
commercial strategies for pharmaceutical, biotech, and medical device companies, from clinical, through manufacturing, contracting, commercial compliance, and Government Programs.
CIS provides its clients with a deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions to guide them to a better "Culture of Compliance" that is both meaningful and sustainable. For more information, visit